Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Un confronto randomizzato tra cure personalizzate basato sulla stadiazione della malattia cardiaca e sulle cure abituali per la prevenzione degli eventi (TRANSFORM)

25 settembre 2026 aggiornato da: Cleerly, Inc.

Confronto randomizzato tra cure personalizzate basato sulla stadiazione della malattia coronarica e cure usuali per la prevenzione primaria degli eventi cardiovascolari

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.

Panoramica dello studio

Descrizione dettagliata

Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.

This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.

This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.

Tipo di studio

Interventistico

Iscrizione (Stimato)

7500

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Arizona
      • Chandler, Arizona, Stati Uniti, 85224
        • Reclutamento
        • Chandler Clinical Trials
        • Contatto:
          • Muhammad Salim, MD
      • Scottsdale, Arizona, Stati Uniti, 85260
        • Reclutamento
        • Scottsdale Clinical Trials
        • Contatto:
          • Todd Dreitzler, MD
      • Sun City, Arizona, Stati Uniti, 85381
        • Reclutamento
        • Sun City Research
        • Contatto:
          • Juan Rodriguez, MD
      • Tucson, Arizona, Stati Uniti, 85704
        • Reclutamento
        • Noble Clinical Research
        • Contatto:
          • Roxana Rodriguez, MD
    • California
      • Beverly Hills, California, Stati Uniti, 90210
        • Reclutamento
        • Cardiovascular Research Foundation of Southern California
        • Contatto:
          • Ronald P. Karlsberg, MD
      • Beverly Hills, California, Stati Uniti, 90211
        • Reclutamento
        • Amicis Research: Beverly Hills
        • Contatto:
          • Michael Levine, MD
      • Canoga Park, California, Stati Uniti, 91303
        • Reclutamento
        • Valiance Clinical Research - Canoga Park
        • Contatto:
          • Rami Shaarawy
      • Chula Vista, California, Stati Uniti, 91911
        • Reclutamento
        • Cardiovascular Institute of San Diego
        • Contatto:
          • Milind D. Parikh, MD
      • Granada Hills, California, Stati Uniti, 91324
        • Reclutamento
        • Amicis Research: Granada Hills
        • Contatto:
          • Pascal Dabel, MD
      • Huntington Park, California, Stati Uniti, 90255
        • Reclutamento
        • Valiance Clinical Research: Huntington Park
        • Contatto:
          • Philip Kim, MD
      • Indian Wells, California, Stati Uniti, 92210
        • Reclutamento
        • HALO Diagnostics
        • Contatto:
          • John F. Feller, MD
      • La Jolla, California, Stati Uniti, 92037
        • Reclutamento
        • Scripps Health
        • Contatto:
          • Elizabeth Epstein, MD
      • Lancaster, California, Stati Uniti, 93534
        • Reclutamento
        • Chemidox Clinical Trials
        • Contatto:
          • Pamela Dewar-DeSilva, MD
      • Loma Linda, California, Stati Uniti, 92354
        • Reclutamento
        • Loma Linda University Health
        • Contatto:
          • Purvi Parwani, MD
      • Long Beach, California, Stati Uniti, 90805
        • Reclutamento
        • Long Beach Research Institute
        • Contatto:
          • Ashley Duzik, MD
      • Monterey Park, California, Stati Uniti, 91754
        • Reclutamento
        • Ace Research Institute - Monterey Park
        • Contatto:
          • Yu-Hsiang Sam Lee, MD
      • Newhall, California, Stati Uniti, 91321
        • Reclutamento
        • Amicis Research: Newhall
        • Contatto:
          • Thuong Vo, MD
      • Northridge, California, Stati Uniti, 91324
        • Reclutamento
        • Ace Research Institute: Northridge
        • Contatto:
          • Richard Park, MD
      • Northridge, California, Stati Uniti, 91324
        • Reclutamento
        • Amicis Research: Northridge
        • Contatto:
          • Nana Barseghian, MD
      • Northridge, California, Stati Uniti, 91325
        • Reclutamento
        • Ace Research Institute: Northridge #2
        • Contatto:
          • William Y. Josephson, MD
      • Northridge, California, Stati Uniti, 91325
        • Attivo, non reclutante
        • Northridge Clinical Trials
      • Orange, California, Stati Uniti, 92868
        • Reclutamento
        • University of California- Irvine
        • Contatto:
          • Ailin Barseghian El-Farra, MD
      • Palo Alto, California, Stati Uniti, 94304
        • Reclutamento
        • Stanford Health Care
        • Contatto:
          • Sandra Tsai, MD
      • Palo Alto, California, Stati Uniti, 94304
        • Reclutamento
        • VA Palo Alto
        • Contatto:
          • Shriram Nallamshetty, MD
      • San Fernando, California, Stati Uniti, 91306
        • Reclutamento
        • Amicis Research: San Fernando
        • Contatto:
          • Farid Yasharpour, MD
      • Tarzana, California, Stati Uniti, 91356
        • Reclutamento
        • Valiance Clinical Research - Tarzana
        • Contatto:
          • Harpreet Singh, MD
      • Torrance, California, Stati Uniti, 90502
        • Reclutamento
        • Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
        • Contatto:
          • Suvasini Lakshmanan, MD
      • Valencia, California, Stati Uniti, 91355
        • Reclutamento
        • Amicis Research: Valencia
        • Contatto:
          • Dennis Lewis, MD
      • Valley Village, California, Stati Uniti, 91607
        • Reclutamento
        • Concierge Clinical Trials
        • Contatto:
          • Neal R. Cutler, MD
    • Colorado
      • Aurora, Colorado, Stati Uniti, 80045
        • Reclutamento
        • University of Colorado
        • Contatto:
          • Steve Simon
        • Investigatore principale:
          • Steve Simon, MD
      • Denver, Colorado, Stati Uniti, 80218
        • Reclutamento
        • St. Josephs (Intermountain Healthcare)
        • Contatto:
          • Christopher Angus, MD
    • Florida
      • Boca Raton, Florida, Stati Uniti, 33434
        • Reclutamento
        • Flourish Medical Research
        • Contatto:
          • Michael Hafran, MD
      • Cross City, Florida, Stati Uniti, 32628
        • Reclutamento
        • Apex Research
        • Contatto:
          • Tamir Salmani, MD
      • Hialeah, Florida, Stati Uniti, 33012
        • Reclutamento
        • Evolution Research Center
        • Contatto:
          • Riquel Gonzalez, MD
      • Jacksonville, Florida, Stati Uniti, 32209
        • Reclutamento
        • UF Health Jacksonville
        • Contatto:
          • Luis Ortega Paz, MD
      • Miami, Florida, Stati Uniti, 33137
        • Reclutamento
        • BioPhase Research
        • Contatto:
          • Julie Cadet-Plassman, MD
      • Miami, Florida, Stati Uniti, 33135
        • Reclutamento
        • Fiel Wellness Clinical Research LLC
        • Contatto:
          • Osvaldo Caroma, MD
      • Miami, Florida, Stati Uniti, 33155
        • Reclutamento
        • United Clinical Research
        • Contatto:
          • Teresa B. Alfonso, MD
        • Contatto:
          • Alfonso
      • Miami, Florida, Stati Uniti, 33173
        • Reclutamento
        • Atlantis Clinical Research, LLC
        • Contatto:
          • Leyvi Alvarado Miranda, MD
      • Miami, Florida, Stati Uniti, 33183
        • Reclutamento
        • Farma Medical Inc.
        • Contatto:
          • Ingrid Fernandez-Milian, MD
      • Miami, Florida, Stati Uniti, 33173
        • Reclutamento
        • Baptist Health Miami Cardiac and Vascular Institute
        • Contatto:
          • Jonathan Fialkow, MD
      • Miami, Florida, Stati Uniti, 33186
        • Reclutamento
        • New Access Research and Medical Center
        • Contatto:
          • Sander Fernandez, MD
      • Miami Beach, Florida, Stati Uniti, 33140
        • Reclutamento
        • Quantum Clinical Trials
        • Contatto:
          • Christopher A. Fayeghi, MD
      • Pensacola, Florida, Stati Uniti, 32504
        • Reclutamento
        • Ascension Sacred Heart
        • Contatto:
          • Rohit Amin, MD
      • Pompano Beach, Florida, Stati Uniti, 33060
        • Reclutamento
        • Clinical Research Center of Florida
        • Contatto:
          • Howard S. Koch, MD
      • Tampa, Florida, Stati Uniti, 33620
        • Reclutamento
        • University of South Florida
        • Contatto:
          • Shone Almeida, MD
    • Georgia
      • Augusta, Georgia, Stati Uniti, 30907
        • Reclutamento
        • Aiyan Diabetes Center
        • Contatto:
          • Anthony D. Turner, MD
      • Dunwoody, Georgia, Stati Uniti, 30338
        • Reclutamento
        • Emory University
        • Contatto:
          • Ambar Kulshreshtha, MD
      • Fayetteville, Georgia, Stati Uniti, 30214
        • Reclutamento
        • Privia Medical Group Georgia LLC -Fayetteville (Javara)
        • Contatto:
          • Charlotte Grayson Mathis, MD
      • Lithia Springs, Georgia, Stati Uniti, 30122
        • Reclutamento
        • Randomize Now- Atlanta West
        • Contatto:
          • Millard Collier Jr., MD
      • Macon, Georgia, Stati Uniti, 31210
        • Reclutamento
        • Randomize Now-Burton Medical
        • Contatto:
          • Frederick Burton, MD
      • Norcross, Georgia, Stati Uniti, 30092
        • Reclutamento
        • Evergreen Clinical Trials
        • Contatto:
          • Dmitriy Pelishev, MD
      • Powder Springs, Georgia, Stati Uniti, 30127
        • Reclutamento
        • Peachtree Clinical Solutions - Noir Research Collective
        • Contatto:
          • Karan Raghavan, MD
      • Riverdale, Georgia, Stati Uniti, 30296
        • Reclutamento
        • Randomize Now, LLC - Noir Research Collective
        • Contatto:
          • Claire K. Willie, MD
      • Savannah, Georgia, Stati Uniti, 31406
        • Reclutamento
        • Privia Medical Group Georgia, LLC (Javara Inc.)
        • Contatto:
          • Thomas G. Moriarity, MD
      • Thomasville, Georgia, Stati Uniti, 31792
        • Reclutamento
        • Privia Medical Group Georgia - Thomasville (Javara)
        • Contatto:
          • William L. Cooper, MD
    • Idaho
      • Meridian, Idaho, Stati Uniti, 83642
        • Reclutamento
        • Care Institute- High Desert
        • Contatto:
          • David A. Hinchman, MD
    • Illinois
      • Chicago, Illinois, Stati Uniti, 60611
        • Reclutamento
        • Northwestern University
        • Contatto:
          • Paul C. Cremer, MD
      • Glenview, Illinois, Stati Uniti, 60026
        • Reclutamento
        • Northshore University Health System
        • Contatto:
          • Amit K. Pursnani, MD
    • Indiana
      • Indianapolis, Indiana, Stati Uniti, 46237
        • Reclutamento
        • Franciscan Physician Network- Indiana Heart Physicians
        • Contatto:
          • Ryan P Daly, MD
      • Indianapolis, Indiana, Stati Uniti, 46202
        • Reclutamento
        • Indiana Medical Research Institute
        • Contatto:
          • Arshad P. Malik
    • Iowa
      • West Des Moines, Iowa, Stati Uniti, 50266
        • Reclutamento
        • MercyOne Iowa Heart Center
        • Contatto:
          • Enrico L. Martin, MD
    • Kentucky
      • Edgewood, Kentucky, Stati Uniti, 41017
        • Reclutamento
        • St Elizabeth Health Care - CRI
        • Contatto:
          • Erica Pivato, MD
      • Louisville, Kentucky, Stati Uniti, 40202
        • Reclutamento
        • UofL Health
        • Contatto:
          • Shahab Ghafghazi, MD
    • Louisiana
      • New Orleans, Louisiana, Stati Uniti, 70127
        • Reclutamento
        • Ascension DePaul Services Research Center
        • Contatto:
          • Kristen Thomas, MD
    • Maryland
      • Bowie, Maryland, Stati Uniti, 20715
        • Reclutamento
        • Flourish Bowie dba Flourish Research
        • Contatto:
          • Sara Collins, MD
      • Columbia, Maryland, Stati Uniti, 21045
        • Reclutamento
        • KUR Research at CMP
        • Contatto:
          • William Saway, MD
    • Massachusetts
      • Boston, Massachusetts, Stati Uniti, 02115
        • Reclutamento
        • Brigham and Women's Hospital
        • Contatto:
          • Ron Blankstein, MD
      • Boston, Massachusetts, Stati Uniti, 02114
        • Reclutamento
        • Massachusetts General Hospital
        • Contatto:
          • Pradeep Natarajan, MD
    • Michigan
      • Detroit, Michigan, Stati Uniti, 48202
        • Reclutamento
        • Henry Ford Hospital
        • Contatto:
          • Cori E Russell, MD
      • Ypsilanti, Michigan, Stati Uniti, 48917
        • Reclutamento
        • Trinity Health Michigan Heart
        • Contatto:
          • Ahmad Mizyed, MD
    • Minnesota
      • Minneapolis, Minnesota, Stati Uniti, 55407
        • Reclutamento
        • Minneapolis Heart Institute Foundation
        • Contatto:
          • Michael D. Miedema, MD
    • Missouri
      • St Louis, Missouri, Stati Uniti, 63110
        • Reclutamento
        • Washington University School of Medicine
        • Contatto:
          • Farhan M. Katchi, MD
      • St Louis, Missouri, Stati Uniti, 63136
        • Reclutamento
        • Saint Louis Heart and Vascular
        • Contatto:
          • Gil Vardi, MD
    • Montana
      • Kalispell, Montana, Stati Uniti, 59901
        • Reclutamento
        • Boeson Research Kalispell
        • Contatto:
          • Justin Buls, MD
      • Missoula, Montana, Stati Uniti, 59804
        • Reclutamento
        • Boeson Research Fort Missoula
        • Contatto:
          • Audrey Remmers, MD
    • Nebraska
      • Lincoln, Nebraska, Stati Uniti, 68506
        • Reclutamento
        • Bryan Heart
        • Contatto:
          • Chad E. Travers, MD
    • Nevada
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Reclutamento
        • Vector Clinical Trials
        • Contatto:
          • Bharat R. Mocherla, MD
      • Las Vegas, Nevada, Stati Uniti, 89102
        • Reclutamento
        • Southwest Medical Associates- Optum Nevada
        • Contatto:
          • Tatiana O. Tsvetkova, MD
    • New Jersey
      • Flemington, New Jersey, Stati Uniti, 08822
        • Reclutamento
        • Advanced Heart and Vascular Institute of Hunterdon
        • Contatto:
          • Andrey Espinoza, MD
      • Marlton, New Jersey, Stati Uniti, 08053
        • Reclutamento
        • Virtua Health, Inc.
        • Contatto:
          • Mark T. Finch, MD
      • New Brunswick, New Jersey, Stati Uniti, 08901
        • Reclutamento
        • Rutgers State University
        • Contatto:
          • Sabahat Bokhari, MD
      • Paramus, New Jersey, Stati Uniti, 07652
        • Reclutamento
        • The Valley Hospital
        • Contatto:
          • Himanshu Gupta, MD
      • Teaneck, New Jersey, Stati Uniti, 07666
        • Reclutamento
        • Holy Name Medical Center
        • Contatto:
          • Jaffar Raza, MD
    • New York
      • Brooklyn, New York, Stati Uniti, 11221
        • Reclutamento
        • Clindove Research
        • Contatto:
          • Nelly Cohen, MD
      • Brooklyn, New York, Stati Uniti, 11226
        • Reclutamento
        • Swift Clinical Research
        • Contatto:
          • Manoj Dalmia, MD
      • Jackson Heights, New York, Stati Uniti, 11372
        • Reclutamento
        • Rasaj Research
        • Contatto:
          • Ammara Mushtaq, MD
      • Lake Success, New York, Stati Uniti, 11042
        • Reclutamento
        • Optum- Long Island NY
        • Contatto:
          • Steven Goldberg, MD
      • Mount Kisco, New York, Stati Uniti, 10549
        • Reclutamento
        • Northwell Health Northern Westchester Hospital
        • Contatto:
          • Margaret Andersen, MD
      • New York, New York, Stati Uniti, 10019
        • Reclutamento
        • Mount Sinai West
        • Contatto:
          • Waqas A Malick, MD
      • New York, New York, Stati Uniti, 10029
        • Reclutamento
        • Mount Sinai
        • Contatto:
          • Solomon Bienstock, MD
    • North Carolina
      • Chapel Hill, North Carolina, Stati Uniti, 27599
        • Reclutamento
        • University of North Carolina at Chapel Hill
        • Contatto:
          • Matthew Cavender, MD
      • Durham, North Carolina, Stati Uniti, 27701
        • Reclutamento
        • Duke University Hospital
        • Contatto:
          • William Yancy, MD
      • Durham, North Carolina, Stati Uniti, 27705
        • Reclutamento
        • Durham Veterans Affairs Medical Center (Durham VAMC)
        • Contatto:
          • Hayden Bosworth, MD
      • Fayetteville, North Carolina, Stati Uniti, 28304
        • Reclutamento
        • Cape Fear Valley Health System (Javara Inc.)
        • Contatto:
          • Nafisa Saleem, MD
      • Morehead City, North Carolina, Stati Uniti, 28557
        • Attivo, non reclutante
        • West Clinical Research
      • Winston-Salem, North Carolina, Stati Uniti, 27157
        • Reclutamento
        • Wake Forest University Health Sciences
        • Contatto:
          • Michael Shapiro, MD
    • North Dakota
      • Fargo, North Dakota, Stati Uniti, 58102
        • Reclutamento
        • Sanford Health
        • Contatto:
          • David J. Clardy, MD
    • Ohio
      • Akron, Ohio, Stati Uniti, 44304
        • Reclutamento
        • Summa Health
        • Contatto:
          • Wissam Alajaji, MD
    • Oklahoma
      • Oklahoma City, Oklahoma, Stati Uniti, 73109
        • Reclutamento
        • Medical Research International, LLC
        • Contatto:
          • Joseph Grillo, MD
      • Oklahoma City, Oklahoma, Stati Uniti, 73007
        • Reclutamento
        • Hightower Clinical
        • Contatto:
          • Faisal Latif, MD
      • Tulsa, Oklahoma, Stati Uniti, 74104
        • Reclutamento
        • Ascension St. John - Jane Phillips Medical Center
        • Contatto:
          • Michael Megaly, MD
    • Pennsylvania
      • Camp Hill, Pennsylvania, Stati Uniti, 17011
        • Reclutamento
        • Capital Area Research
        • Contatto:
          • Venkatesh Nadar, MD
    • South Carolina
      • Charleston, South Carolina, Stati Uniti, 29425
        • Reclutamento
        • Medical University of South Carolina
        • Contatto:
          • Marc-Andre Cornier, MD
    • Tennessee
      • Cleveland, Tennessee, Stati Uniti, 37312
        • Reclutamento
        • Community DPC
        • Contatto:
          • Carlton Volberg, MD
      • Knoxville, Tennessee, Stati Uniti, 37920
        • Reclutamento
        • University of Tennessee Medical Center
        • Contatto:
          • Kashif A. Shaikh, MD
      • Nashville, Tennessee, Stati Uniti, 37202
        • Reclutamento
        • TriStar Centennial Medical Center (HCA Health Care)
        • Contatto:
          • David Huneycutt, MD
    • Texas
      • Abilene, Texas, Stati Uniti, 79601
        • Reclutamento
        • Hendrick Health
        • Contatto:
          • Ren Zhang, MD
      • Beaumont, Texas, Stati Uniti, 77702
        • Reclutamento
        • Gadolin Research
        • Contatto:
          • John T Fowler, MD
      • Greenville, Texas, Stati Uniti, 75402
        • Reclutamento
        • CardioVoyage, LLC
        • Contatto:
          • Marc Demyun, MD
      • Houston, Texas, Stati Uniti, 77025
        • Reclutamento
        • Kelsey Research Foundation
        • Contatto:
          • Rohan R Wagle, MD
      • Houston, Texas, Stati Uniti, 77004
        • Reclutamento
        • Helium Research Group
        • Contatto:
          • Ijeoma A. Ekeruo
      • Houston, Texas, Stati Uniti, 77070
        • Reclutamento
        • Gulf Coast Clinical Research, LLC
        • Contatto:
          • Anjani Pandya, MD
      • Houston, Texas, Stati Uniti, 77030
        • Reclutamento
        • The Methodist Hospital, DeBakey Cardiology Associates
        • Contatto:
          • Sadeer Al-Kindi, MD
      • Laredo, Texas, Stati Uniti, 78041
        • Reclutamento
        • Aeres Clinical Research
        • Contatto:
          • Amando Garza, MD
      • Lewisville, Texas, Stati Uniti, 75057
        • Reclutamento
        • DC Clinical Research
        • Contatto:
          • Moiz M. Shafiq, MD
      • McKinney, Texas, Stati Uniti, 75069
        • Reclutamento
        • North Dallas Research Associates - Kerlo Network
        • Contatto:
          • Muhammad Akram Khan, MD
      • Mesquite, Texas, Stati Uniti, 75149
        • Reclutamento
        • SMS Clinical Research
        • Contatto:
          • Salma Saiger, MD
      • San Marcos, Texas, Stati Uniti, 78666
        • Reclutamento
        • Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
        • Contatto:
          • Alan Lee, MD
      • Stephenville, Texas, Stati Uniti, 76401
        • Reclutamento
        • Privia Medical Group- North Texas
        • Contatto:
          • Benjamin Marcum, MD
    • Utah
      • West Valley City, Utah, Stati Uniti, 84120
        • Non ancora reclutamento
        • Kalo Clinical Research
        • Contatto:
          • William J. Walsh, MD
    • Virginia
      • Richmond, Virginia, Stati Uniti, 23225
        • Reclutamento
        • Chippenham Johnston Willis Medical Center
        • Contatto:
          • Michael Arcarese, MD
    • Washington
      • Everett, Washington, Stati Uniti, 98201
        • Reclutamento
        • Providence Regional Medical Center Everett
        • Contatto:
          • Xiaojing Jennie Shen, MD
      • Seattle, Washington, Stati Uniti, 98195
        • Reclutamento
        • University of Washington
        • Contatto:
          • Kelley Branch, MD
    • West Virginia
      • Charleston, West Virginia, Stati Uniti, 25304
        • Reclutamento
        • Charleston Area Medical Center
        • Contatto:
          • Sarah Rinehart, MD

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

55 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  1. Provided electronic or written informed consent

  2. Men > 55, women > 65 years of age

  3. Type 2 diabetes mellitus requiring pharmacologic therapy, prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):

    • Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
    • Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
    • HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
    • Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
    • Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
  4. Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group

Exclusion Criteria:

  1. History of symptomatic CVD defined as prior MI, exertional or unstable angina, ischemic stroke, claudication, arterial revascularization for atherosclerosis or other CVD being actively managed by a cardiologist, e.g. atrial fibrillation, heart failure

  2. Planned arterial revascularization

  3. Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:

    1. eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
    2. Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
    3. Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
    4. Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
    5. Inability to hold breath for > 10 seconds
    6. Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
    7. Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
    8. Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
  4. Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Risk Factor-Based Care

The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study.

Sperimentale: Cleerly Stage-Based Care

The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months.

The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
Lasso di tempo: Through study completion- an average of 3.5 years

The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure.

Through study completion- an average of 3.5 years

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Lasso di tempo: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Lasso di tempo: Through study completion- an average of 3.5 years

The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Lasso di tempo: Through study completion- an average of 3.5 years

The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Lasso di tempo: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Lasso di tempo: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to all-cause death.

Through study completion- an average of 3.5 years

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
The safety objective is to assess harm with the 2 prevention strategies
Lasso di tempo: Through study completion- an average of 3.5 years

The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE).

Through study completion- an average of 3.5 years
The safety objective is to assess harm with the 2 prevention strategies
Lasso di tempo: Through study completion- an average of 3.5 years

The safety endpoints are 20-item Short Form survey (SF-20).

Through study completion- an average of 3.5 years

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Cattedra di studio: Deepak Bhatt, MD, MPH, Mt. Sinai Heart
  • Cattedra di studio: David J. Maron, MD, FASPC, Stanford University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

6 marzo 2024

Completamento primario (Stimato)

5 marzo 2029

Completamento dello studio (Stimato)

5 marzo 2029

Date di iscrizione allo studio

Primo inviato

2 ottobre 2023

Primo inviato che soddisfa i criteri di controllo qualità

31 ottobre 2023

Primo Inserito (Effettivo)

1 novembre 2023

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

28 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

25 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi